Quarter Financials
BioXcel Therapeutics, Inc. (BTAI)
$2.37
-0.16 (-6.32%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -54 | -51 | -58 | -45 | -39 | -31 | -26 | -27 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -518 | -464 | -412 | -357 | -315 | -277 | -246 | -220 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | -0 | - | -0 | - | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|